Somatic disease in survivors of childhood malignant bone tumors in the nordic countries

• Published in: Cancers
• Main Authors: Pedersen, Camilla, Rechnitzer, Catherine, Andersen, Elisabeth Anne Wreford, Kenborg, Line, Norsker, Filippa Nyboe, Bautz, Andrea, Baad-Hansen, Thomas, Tryggvadottir, Laufey, Madanat-Harjuoja, Laura Maria, Holmqvist, Anna Sällfors, Hjorth, Lars, Hasle, Henrik, Winther, Jeanette Falck
• Format: Article in Journal/Newspaper
• Language: English
• Published: 2021
• Subjects: Childhood malignant bone tumors; Cohort study; Late effects; Somatic disease; Survivorship; Ewing; Iceland
• Online Access: https://pure.au.dk/portal/en/publications/2bcf3ace-b290-489e-a88b-f5d51fd674d1; https://doi.org/10.3390/cancers13184505; http://www.scopus.com/inward/record.url?scp=85114315951&partnerID=8YFLogxK

Survivors of malignant bone tumors in childhood are at risk of long-term adverse health effects. We comprehensively reviewed cases of somatic diseases that required a hospital contact in survivors of osteosarcoma and Ewing sarcoma. In a population-based cohort study, 620 five-year survivors of osteosarcoma (n = 440) or Ewing sarcoma (n = 180), diagnosed before the age of 20 years in Denmark, Finland, Iceland, and Sweden during 1943–2008, were followed in the national hospital registers. Overall rates of hospital contacts for any somatic disease and for 12 main diagnostic groups and 120 specific disease categories were compared with those in a matched comparison cohort (n = 3049) randomly selected from the national population registers. The rate of hospital contact for any somatic disease was 80% higher in survivors of malignant bone tumors than in comparisons and remained elevated up to 30 years after diagnosis. The rate of hospital contacts was higher after Ewing sarcoma (rate ratio (RR) 2.24; 95% confidence interval (CI) 1.76–2.85) than after osteosarcoma (RR 1.67; 95% CI 1.41–1.98). Elevated rates were observed for 11 main diagnostic groups, including infections, second malignant neoplasms, and diseases of the skin, bones, and circulatory, digestive, endocrine, and urinary systems. Survivors of malignant bone tumors in childhood are at increased risk of somatic diseases many years after diagnosis. This comprehensive study contributes new insight into the risk of late effects in survivors of osteosarcoma and Ewing sarcoma, which is an essential basis for optimal patient counseling and follow-up care.